Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.

Epigenetics - 1 May 2013

Sousa Elsa, Graça Inês, Baptista Tiago, Vieira Filipa Q, Palmeira Carlos, Henrique Rui, Jerónimo Carmen

Abstract excerpt

Prostate cancer (PCa) is one of the most incident malignancies worldwide. Although efficient therapy is available for early-stage PCa, treatment of advanced disease is mainly ineffective and remains a clinical challenge. microRNA (miRNA) dysregulation is associated with PCa development and progre...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DEAD-box RNA Helicases
Share to G1 Phase
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Prostatic Neoplasms

Share to Ribonuclease III

Share to RNA-Binding Proteins

Share to RNA Processing, Post-Transcriptional

Source

Open in PubMed Open full text

Identifiers

PMID: 23644875
DOI: 10.4161/epi.24519
PMCID: PMC3741225

Genes

TARBP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23644875-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.PMID 23644875Read ↗

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.Semantic proximity Read ↗

Therapeutic Potential of miRNAs in Prostate Cancer: From Mechanisms to Targeted Therapy and Clinical ApplicationsSemantic proximity Read ↗

The mechanistic role of long non-coding RNAs in advanced prostate cancer response to therapySemantic proximity Read ↗

Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screeningSemantic proximity Read ↗

Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer CellsSemantic proximity Read ↗

Suppression of ANT2 by miR-137 Inhibits Prostate TumorigenesisSemantic proximity Read ↗

Resveratrol and prostate cancer: Promising role for microRNAsSemantic proximity Read ↗

Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate CancerSemantic proximity Read ↗

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerSemantic proximity Read ↗

The roles of microRNAs in the progression of castration-resistant prostate cancerSemantic proximity Read ↗

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerSemantic proximity Read ↗

Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.